期刊文献+

雷贝拉唑治疗幽门螺杆菌相关性胃溃疡的效果分析 被引量:3

Effect of rabeprazole in the treatment of Helicobacter pylori associated gastric ulcer
下载PDF
导出
摘要 目的:探讨雷贝拉唑治疗幽门螺杆菌(Hp)相关性胃溃疡的效果。方法:收治Hp感染胃溃疡患者90例,分为参照组和试验组。两组均接受阿莫西林、克拉霉素、枸橼酸铋钾治疗。在此基础上,参照组采用奥美拉唑治疗,试验组采用雷贝拉唑治疗,比较两组治疗效果。结果:治疗后,试验组症状评分改善情况、总有效率和血清炎性因子均明显优于参照组(P<0.05)。结论:雷贝拉唑治疗Hp感染胃溃疡的效果显著,安全性高。 Objective:To explore the effect of rabeprazole in the treatment of Helicobacter pylori(Hp) associated gastric ulcer.Methods:90 patients with Helicobacter pylori associated gastric ulcer were selected.They were divided into the reference group and the experimental group.The two groups were treated with amoxicillin,clarithromycin and potassium bismuth citrate.On this basis,the reference group was treated with omeprazole,and the experimental group was treated with rabeprazole.We compared the therapeutic effect of two groups.Results:After treatment,the improvement of symptom score,total effective rate and serum inflammatory factor in the experimental group were obviously superior to those of the reference group(P〈0.05).Conclusion:The effect of rabeprazole in the treatment of Hp associated gastric ulcer was significant,and the security was high.
作者 全红梅 金哲
出处 《中国社区医师》 2018年第7期39-40,42,共3页 Chinese Community Doctors
关键词 雷贝拉唑 幽门螺杆菌 胃溃疡 Rabeprazole Helicobacter pylori Gastric ulcer
  • 相关文献

参考文献6

二级参考文献43

  • 1雷贝拉唑多中心临床观察协作组.雷贝拉唑对胃溃疡患者胃内pH值的影响[J].中华内科杂志,2004,43(9):675-678. 被引量:39
  • 2Muhammad JS, Zaidi SF, Sugiyama T. Epidemiological ins and outs of helicobacter pylori: a review[ J]. J Pak Med Assoc, 2012, 62(9) :955-959.
  • 3Marelli S, Pace F. Rabeprazole for the treatment of acid-related disorders[J]. Expert Rev Gastroenterol Hepatol, 2012,6 (4): 423 -435.
  • 4Sanuki T, Fujita T, Kutsumi H, et al. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or eerebrovascular disease: a prospec- tive randomized active-controlled trial[ J ]. J Gastroenterol, 2012, 47( 11 ) :1186-1197.
  • 5Sugizaki K, Sakata Y, Arai T, et al. A multicenter prospective observational study of triple therapy with rabeprazole, amoxicillin and metronidazole for Helicobaeter pylori in Japan [ J ]. Intern Med. 2012.51 (22) :3103-3108.
  • 6Schaper NC, Dryden M, Kujath P, et al. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by POamoxicillin/clavulanic acid in the treatment of diabetic foot infec-tions: Results of the RELIEF study [J]. Infection, 2013,41(1):175-186.
  • 7Sanuki T, Fujita T, Kutsumi H, et al. Rabeprazole reduces the recur-rence risk of peptic ulcers associated with low-dose aspirin in pa-tients with cardiovascular or cerebrovascular disease: A prospectiverandomized active-controlled trial[J]. J Gastroenterol, 2012,47(11):1186-1197.
  • 8Luo JC, Huang KW, Leu HB, et al. Randomised clinical trial:rabeprazole plus aspirin is not inferior to rabeprazole plus clopido-grel for the healing of aspirin -related peptic ulcer [J], AlimentPharmacol Ther, 2011,34(5):519-525.
  • 9柏依海,王红霞,文继平,闵丽萍,伍良知.雷贝拉唑三联疗法治疗消化性溃疡89例疗效观察[J】.中国现代药物应用,2012,11(04):36-38.
  • 10尚惺杰,王昌雄,陈光兰,黎红光,徐伟红,叶洁桐.雷贝拉唑联合瑞巴派特治疗活动性胃溃疡36例[J].医药导报,2010,29(8):1010-1012. 被引量:30

共引文献116

同被引文献21

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部